Strategic Partnerships Leverage existing collaboration with Cedars-Sinai and other large hospitals as credibility hooks to expand to top-tier health systems and academic medical centers. Position Luminare’s sepsis optimization as a value-add to high-performance institutions seeking marginal gains in patient outcomes and compliance.

Product Expansion Opportunity to upsell or bundle Sagitta sepsis detection with additional hospital ancillary solutions such as automated vaccine management and screening tools piloted with Geocon and Martin Foods. Target hospitals with high sepsis risk, large patient volumes, and complex care pathways.

Tech Enablement Highlight cloud-native and web-optimized tech stack (Cloudflare, HTTP/3, MySQL) to appeal to tech-enabled health systems prioritizing performance, security, and scalable deployments. Emphasize data-driven sepsis detection capabilities and rapid integration with existing EHR/clinical workflows.

Financial Scope With reported revenue between one and ten million, target mid-market and regional health networks seeking proven ROI. Propose outcome-based contracts focused on sepsis reduction, length of stay, readmission rates, and hospital efficiency improvements.

Market Readiness Capitalize on demonstrated use cases in diverse settings (acute care hospitals, microclinics, and vaccine management) to address multiple interoperability needs. Approach health systems expanding infection control, patient screening, and vaccine management programs, especially in post-pandemic operational tune-ups.